FR2408610A1 - Derives de 2,6-diphenyl-3,7-dioxabicyclo-(3,3,0)-octane-4,8-dione, leur procede de preparation et leur application en therapeutique - Google Patents

Derives de 2,6-diphenyl-3,7-dioxabicyclo-(3,3,0)-octane-4,8-dione, leur procede de preparation et leur application en therapeutique

Info

Publication number
FR2408610A1
FR2408610A1 FR7832242A FR7832242A FR2408610A1 FR 2408610 A1 FR2408610 A1 FR 2408610A1 FR 7832242 A FR7832242 A FR 7832242A FR 7832242 A FR7832242 A FR 7832242A FR 2408610 A1 FR2408610 A1 FR 2408610A1
Authority
FR
France
Prior art keywords
group
dioxabicyclo
octane
diphenyl
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7832242A
Other languages
English (en)
Inventor
Hamao Umezawa
Tomio Takeuchi
Masaaki Ishizuka
Yoshiki Kumada
Katsuji Yamashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of FR2408610A1 publication Critical patent/FR2408610A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A.DERIVES DE 2,6-DIPHENYL-3,7-DIOXABICYCLO-3,30-OCTANE-4,8-DIONE, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE. B.CES DERIVES CORRESPONDENT A LA FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE R, R, R ET R REPRESENTE CHACUN DES GROUPEMENTS SEMBLABLES OU DIFFERENTS QUI SONT CHOISIS DANS LE GROUPE COMPRENANT UN GROUPEMENT HYDROXYLE, UN GROUPEMENT ALCOXYLE C C, UN ATOME D'HALOGENE, UN GROUPEMENT THIOALCOXYMETHYLE C C, UN GROUPEMENT ALKYLE C C, UN GROUPEMENT ALCOXYMETHYLE C C, ET UN ATOME D'HYDROGENE, POURVU QUE LES CAS SUIVANTS EN SOIENT EXCLUS; LE CAS OU R ET R ETANT DES GROUPEMENTS HYDROXYLE, R ET R SONT DES ATOMES D'HYDROGENE, LE CAS OU R ETANT UN GROUPEMENT METHOXYLE, R EST UN GROUPEMENT HYDROXYLE, ET R ET R SONT DES ATOMES D'HYDROGENE, LE CAS OU R ETANT UN GROUPEMENT METHOXYLE, R EST UN GROUPEMENT HYDROXYLE, R EST UN GROUPEMENT METHOXYLE ET R EST UN ATOME D'HYDROGENE, ET LE CAS OU R ET R ETANT DES GROUPEMENTS METHOXYLE, R ET R SONT DES ATOMES D'HYDROGENE. C.MEDICAMENTS.
FR7832242A 1977-11-15 1978-11-15 Derives de 2,6-diphenyl-3,7-dioxabicyclo-(3,3,0)-octane-4,8-dione, leur procede de preparation et leur application en therapeutique Withdrawn FR2408610A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13742077A JPS5473789A (en) 1977-11-15 1977-11-15 2,6-diphenyl-3,7-dioxabicyclo-3.3.0-octane 4,8-dione derivative and anticarcinogens, catechol-o-methyl transferase inhibitors and adenosine 3',5'-cyclic phosphoric acid phosphodiesterase inhibitors containing the derivative as active component

Publications (1)

Publication Number Publication Date
FR2408610A1 true FR2408610A1 (fr) 1979-06-08

Family

ID=15198205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7832242A Withdrawn FR2408610A1 (fr) 1977-11-15 1978-11-15 Derives de 2,6-diphenyl-3,7-dioxabicyclo-(3,3,0)-octane-4,8-dione, leur procede de preparation et leur application en therapeutique

Country Status (10)

Country Link
JP (1) JPS5473789A (fr)
AR (1) AR217335A1 (fr)
BE (1) BE871994A (fr)
DE (1) DE2849107A1 (fr)
ES (1) ES475050A1 (fr)
FR (1) FR2408610A1 (fr)
GB (1) GB2010273A (fr)
IT (1) IT1109272B (fr)
NL (1) NL7811308A (fr)
SE (1) SE7811759L (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62581A (ja) * 1985-06-26 1987-01-06 Takemoto Oil & Fat Co Ltd フエノ−ル性天然抗酸化性物質の製造方法
JPS6330416A (ja) * 1986-07-24 1988-02-09 Wakunaga Pharmaceut Co Ltd 脳循環代謝改善剤
US6588625B2 (en) 2001-04-24 2003-07-08 Abbott Laboratories Sample handling system
KR100479405B1 (ko) * 2002-05-24 2005-03-30 주식회사 싸이제닉 신남산 이합체, 그 제조방법 및 퇴행성 뇌질환 치료를위한 그의 용도
JP2011195465A (ja) * 2010-03-17 2011-10-06 Wakayama Prefecture 桂皮酸誘導体の製造方法及び桂皮酸誘導体
JP5914897B2 (ja) * 2012-03-08 2016-05-11 和歌山県 フロフラン誘導体の製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102433A (en) * 1976-02-19 1977-08-27 Microbial Chem Res Found Hypotensive agents containing 1,4-dihydroxy-1,4-di-(3,5-dimethoxy-4-hy droxyphenyl)butane-2,3-dicarboxylic acid dilactone as main component
JPS52136193A (en) * 1976-05-10 1977-11-14 Microbial Chem Res Found Novel dehydrodicaffeic acid dilactone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102433A (en) * 1976-02-19 1977-08-27 Microbial Chem Res Found Hypotensive agents containing 1,4-dihydroxy-1,4-di-(3,5-dimethoxy-4-hy droxyphenyl)butane-2,3-dicarboxylic acid dilactone as main component
JPS52136193A (en) * 1976-05-10 1977-11-14 Microbial Chem Res Found Novel dehydrodicaffeic acid dilactone

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA1935 *
CA1978 *
EXBK/76 *

Also Published As

Publication number Publication date
SE7811759L (sv) 1979-05-16
ES475050A1 (es) 1979-04-16
DE2849107A1 (de) 1979-05-17
JPS5473789A (en) 1979-06-13
IT7851906A0 (it) 1978-11-15
GB2010273A (en) 1979-06-27
NL7811308A (nl) 1979-05-17
IT1109272B (it) 1985-12-16
AR217335A1 (es) 1980-03-14
BE871994A (fr) 1979-05-14

Similar Documents

Publication Publication Date Title
FR2451913A1 (fr) Derives de la glycinamide, leur preparation et leur utilisation dans le traitement de diverses formes d'epilepsie, des dyskinesies et des troubles de la memoire
FR2414039A1 (fr) Derives de prostacycline, leur procede de preparation et leurs applications en therapeutique
FR2440360A1 (fr) Nouveaux derives de 4-((3,4-dialcoxyphenyl)-alkyl)-2-imidazolidinones et leur procede de preparation et medicaments les contenant
FR2370731A1 (fr) Nouveaux derives de la piperidine polysubstitues, leurs procedes de preparation et leur application pharmaceutique
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
TNSN87086A1 (fr) Derives du nitrofuranne, leur preparation et leur application en therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
BE900842A (fr) Nouveaux complexes de platine et leur application en therapeutique.
FR2449682A1 (fr) Derives d'acide quinoleine-carboxylique et leur utilisation en tant qu'agents antimicrobiens
FR2408610A1 (fr) Derives de 2,6-diphenyl-3,7-dioxabicyclo-(3,3,0)-octane-4,8-dione, leur procede de preparation et leur application en therapeutique
FR2455890A1 (fr) Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences
BE905110A (fr) Poly-4-aminopyrrole-2-carboxamides et derives, procede pour leur preparation et leurs utilisations therapeutiques.
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2506772A1 (fr) Glycosides d'anthracycline, procede pour les preparer et leur usage comme medicament
FR2383930A1 (fr) Ethers aminoalcoyliques de pyridinyle, leurs procedes d'obtention et preparations pharmaceutiques les contenant
FR2433540A1 (fr) Nouveaux derives de chlorambucil, conjugues de chlorambucil et d'oestradiol, leur procede de preparation et leur application en therapeutique
FR2456097A1 (fr) Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique
FR2408608A1 (fr) Nouvel antibiotique denomme ps-5 et ses derives doues d'activite inhibitrice de la b-lactamase et leur procede de preparation
FR2440951A1 (fr) Nouveaux derives de la tetrahydroxanthone, leur procede de preparation et leur application en therapeutique
FR2439792A1 (fr) Nouvelles anthracyclines antitumorales contenant des desoxyaminosucres, procede pour les preparer et leur emploi comme medicaments
FR2506313A1 (fr) Derives de l'acide n-acetylneuraminique et leur preparation
FR2413370A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation
FR2421181A1 (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
FR2390445A1 (fr) Nouveaux derives du chromene, leur procede de preparation et leurs applications en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse